Clinical Trial Update: Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases [Phase 1, Phase 2]

View source ↗

Summary

An update on the safety and efficacy of DC-CIK cell therapy in patients with advanced non-small-cell lung cancer with bone metastases, spanning Phase 1 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DC-CIK

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Non-Small-Cell Lung Cancer With Bone Metastases | Phase 1, Phase 2 | Status: UNKNOWN